VTGN VISTAGEN THERAPEUTICS INC Other Situations 8-K Filing 2023 - Update on Clinical Development Programs and Financial Results Vistagen Therapeutics, Inc. filed a letter providing an update on the progress of its clinical development programs and financial results.Get access to all SEC 8-K filings of the VISTAGEN THERAPEUTICS INC